Sign in or Register   Sign in or Register
  |  

Rabbit Anti-IFIH1 (AA 883-1025 ) Recombinant Antibody (CBFYM-1142) (CBMAB-M1299-FY)

This product is rabbit antibody that recognizes IFIH1. The antibody CBFYM-1142 can be used for immunoassay techniques such as: FC, ICC, IF, IHC-P, WB.
See all IFIH1 antibodies

Summary

Host Animal
Rabbit
Specificity
Human, Mouse
Clone
CBFYM-1142
Antibody Isotype
IgG
Application
FC, ICC, IF, IHC-P, WB

Basic Information

Immunogen
A recombinant protein corresponding to amino acids 883-1025 of Q9BYX4
Specificity
Human, Mouse
Antibody Isotype
IgG
Clonality
Monoclonal
Application Notes
The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.

Formulations & Storage [For reference only, actual COA shall prevail!]

Format
Liquid
Buffer
PBS
Preservative
0.09% Sodium azide
Concentration
0.5 mg/mL
Storage
Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
Epitope
AA 883-1025

Target

Full Name
interferon induced with helicase C domain 1
Introduction
DEAD box proteins, characterized by the conserved motif Asp-Glu-Ala-Asp, are putative RNA helicases. They are implicated in a number of cellular processes involving alteration of RNA secondary structure such as translation initiation, nuclear and mitochondrial splicing, and ribosome and spliceosome assembly. Based on their distribution patterns, some members of this family are believed to be involved in embryogenesis, spermatogenesis, and cellular growth and division. This gene encodes a DEAD box protein that is upregulated in response to treatment with beta-interferon and a protein kinase C-activating compound, mezerein. Irreversible reprogramming of melanomas can be achieved by treatment with both these agents; treatment with either agent alone only achieves reversible differentiation. Genetic variation in this gene is associated with diabetes mellitus insulin-dependent type 19.
Entrez Gene ID
Human64135
Mouse71586
UniProt ID
HumanQ9BYX4
MouseQ8R5F7
Alternative Names
Interferon Induced With Helicase C Domain 1
Function
Innate immune receptor which acts as a cytoplasmic sensor of viral nucleic acids and plays a major role in sensing viral infection and in the activation of a cascade of antiviral responses including the induction of type I interferons and proinflammatory cytokines (PubMed:33727702).

Its ligands include mRNA lacking 2'-O-methylation at their 5' cap and long-dsRNA (>1 kb in length). Upon ligand binding it associates with mitochondria antiviral signaling protein (MAVS/IPS1) which activates the IKK-related kinases: TBK1 and IKBKE which phosphorylate interferon regulatory factors: IRF3 and IRF7 which in turn activate transcription of antiviral immunological genes, including interferons (IFNs); IFN-alpha and IFN-beta. Responsible for detecting the Picornaviridae family members such as encephalomyocarditis virus (EMCV) and mengo encephalomyocarditis virus (ENMG). Detects coronavirus SARS-CoV-2 (PubMed:33440148, PubMed:33514628).

Can also detect other viruses such as dengue virus (DENV), west Nile virus (WNV), and reovirus. Also involved in antiviral signaling in response to viruses containing a dsDNA genome, such as vaccinia virus. Plays an important role in amplifying innate immune signaling through recognition of RNA metabolites that are produced during virus infection by ribonuclease L (RNase L). May play an important role in enhancing natural killer cell function and may be involved in growth inhibition and apoptosis in several tumor cell lines.
Biological Process
Cellular response to exogenous dsRNA Source: UniProtKB
Cellular response to virus Source: ARUK-UCL
Cytoplasmic pattern recognition receptor signaling pathway in response to virus Source: UniProtKB
Defense response to virus Source: UniProtKB
Detection of virus Source: BHF-UCL
Innate immune response Source: GO_Central
MDA-5 signaling pathway Source: UniProtKB
Negative regulation of viral genome replication Source: UniProtKB
Positive regulation of interferon-alpha production Source: UniProtKB
Positive regulation of interferon-beta production Source: UniProtKB
Positive regulation of interleukin-6 production Source: UniProtKB
Positive regulation of response to cytokine stimulus Source: UniProtKB
Positive regulation of tumor necrosis factor production Source: UniProtKB
Protein sumoylation Source: UniProtKB
Regulation of type III interferon production Source: UniProtKB
Response to virus Source: UniProtKB
Cellular Location
Cytoplasm; Mitochondrion; Nucleus. Upon viral RNA stimulation and ISGylation, translocates from cytosol to mitochondrion. May be found in the nucleus, during apoptosis.
Involvement in disease
Diabetes mellitus, insulin-dependent, 19 (IDDM19):
A multifactorial disorder of glucose homeostasis that is characterized by susceptibility to ketoacidosis in the absence of insulin therapy. Clinical features are polydipsia, polyphagia and polyuria which result from hyperglycemia-induced osmotic diuresis and secondary thirst. These derangements result in long-term complications that affect the eyes, kidneys, nerves, and blood vessels. IFIH1 is the CADM-140 autoantigen, involved in clinically amyopathic dermatomyositis (CADM). This is a chronic inflammatory disorder that shows typical skin manifestations of dermatomyositis but has no or little evidence of clinical myositis. Anti-CADM-140 antibodies appear to be specific to dermatomyositis, especially CADM. Patients with anti-CADM-140 antibodies frequently develop life-threatening acute progressive interstitial lung disease (ILD).
Aicardi-Goutieres syndrome 7 (AGS7):
A form of Aicardi-Goutieres syndrome, a genetically heterogeneous disease characterized by cerebral atrophy, leukoencephalopathy, intracranial calcifications, chronic cerebrospinal fluid (CSF) lymphocytosis, increased CSF alpha-interferon, and negative serologic investigations for common prenatal infection. Clinical features as thrombocytopenia, hepatosplenomegaly and elevated hepatic transaminases along with intermittent fever may erroneously suggest an infective process. Severe neurological dysfunctions manifest in infancy as progressive microcephaly, spasticity, dystonic posturing and profound psychomotor retardation. Death often occurs in early childhood.
Singleton-Merten syndrome 1 (SGMRT1):
An autosomal dominant disorder with variable expression. Core features are marked aortic calcification, dental anomalies, osteopenia, acro-osteolysis, and to a lesser extent glaucoma, psoriasis, muscle weakness, and joint laxity. Dental anomalies include delayed eruption and immature root formation of anterior permanent teeth, early loss of permanent teeth due to short roots, acute root resorption, high caries, and aggressive alveolar bone loss. Additional clinical manifestations include particular facial characteristics and abnormal joint and muscle ligaments.
PTM
Sumoylated. Sumoylation positively regulates its role in type I interferon induction and is enhanced by PIAS2-beta.
Ubiquitinated by RNF125, leading to its degradation by the proteasome (PubMed:17460044). USP17/UPS17L2-dependent deubiquitination positively regulates the receptor (PubMed:20368735). Ubiquitinated by TRIM25 via 'Lys-63'-linked ubiquitination, promoting activation of IFIH1/MDA5 (PubMed:30193849). Ubiquitinated by TRIM40 via 'Lys-48'-linked ubiquitination; leading to proteasomal degradation (PubMed:29117565).
ISGylated by ISG15. ISGylation increases upon infection with dengue (DENV) or Zika (ZIKV) viruses. ISGylation at Lys-23 and Lys-43 is dependent of dephosphorylation at Ser-88, regulates mitochondrial translocation and oligomerization. Essential for IFIH1/MDA5-mediated cytokine responses and restriction of virus replication.
Phosphorylated at Ser-88. Dephosphorylated by phsophatases PP1; dephosphorylation precedes and is required for ISGylation.
During apoptosis, processed into 3 cleavage products. The helicase-containing fragment, once liberated from the CARD domains, translocate from the cytoplasm to the nucleus. The processed protein significantly sensitizes cells to DNA degradation.By similarity
(Microbial infection) Cleaved and inactivated by the protease 2A of coxsackievirus B3, poliovirus and enterovirus 71 allowing the virus to disrupt the host type I interferon production.

Amado-Rodríguez, L., Del Riego, E. S., de Ona, J. G., Alonso, I. L., Gil-Pena, H., López-Martínez, C., ... & Albaiceta, G. M. (2022). Effects of IFIH1 rs1990760 variants on systemic inflammation and outcome in critically ill COVID-19 patients in an observational translational study. Elife, 11, e73012.

Dieter, C., de Almeida Brondani, L., Lemos, N. E., Schaeffer, A. F., Zanotto, C., Ramos, D. T., ... & Crispim, D. (2022). Polymorphisms in ACE1, TMPRSS2, IFIH1, IFNAR2, and TYK2 genes are associated with worse clinical outcomes in COVID-19. Genes, 14(1), 29.

Zervou, M. I., Andreou, A. C., Eliopoulos, E. E., & Goulielmos, G. N. (2022). Functional significance of the rare rs35667974 IFIH1 gene polymorphism, associated with multiple autoimmune diseases, using a structural biological approach. Autoimmunity, 55(7), 455-461.

Zhang, S., Chu, C., Wu, Z., Liu, F., Xie, J., Yang, Y., & Qiu, H. (2021). IFIH1 contributes to M1 macrophage polarization in ARDS. Frontiers in Immunology, 11, 580838.

Cananzi, M., Wohler, E., Marzollo, A., Colavito, D., You, J., Jing, H., ... & Guerrerio, A. L. (2021). IFIH1 loss-of-function variants contribute to very early-onset inflammatory bowel disease. Human Genetics, 140(9), 1299-1312.

Rice, G. I., Park, S., Gavazzi, F., Adang, L. A., Ayuk, L. A., Van Eyck, L., ... & Crow, Y. J. (2020). Genetic and phenotypic spectrum associated with IFIH1 gain‐of‐function. Human mutation, 41(4), 837-849.

Maiti, A. K. (2020). The African-American population with a low allele frequency of SNP rs1990760 (T allele) in IFIH1 predicts less IFN-beta expression and potential vulnerability to COVID-19 infection. Immunogenetics, 72(6-7), 387-391.

Fischer, H., Tschachler, E., & Eckhart, L. (2020). Pangolins lack IFIH1/MDA5, a cytoplasmic RNA sensor that initiates innate immune defense upon coronavirus infection. Frontiers in immunology, 11, 939.

Liu, N., Chen, J., Xu, C., Shi, T., & Li, J. (2019). Hereditary spastic paraplegia associated with a rare IFIH1 mutation: a case report and literature review. Hereditas, 156(1), 1-4.

Kothur, K., Bandodkar, S., Chu, S., Wienholt, L., Johnson, A., Barclay, P., ... & Dale, R. C. (2018). An open-label trial of JAK 1/2 blockade in progressive IFIH1-associated neuroinflammation. Neurology, 90(6), 289-291.

Ask a question We look forward to hearing from you.
0 reviews or Q&As
Loading...
Have you used Rabbit Anti-IFIH1 (AA 883-1025 ) Recombinant Antibody (CBFYM-1142)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon $30 eGift Card
Submit a review
Loading...
For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Documents

Contact us

  • Tel: (USA)
  • (UK)
  • Fax:
  • Email:

Submit A Review

Go to
Compare